Clinical remission was achieved by significantly more children treated with thalidomide ( 13/28 [ 46.4 % ] vs 3/26 [ 11.5 % ] ; risk ratio [ RR ] , 4.0 [ 95 % CI , 1.2-12 .5 ] ; P = .01 ; number needed to treat [ NNT ] , 2.86 ) .